Shreis Scalene Therapeutics Plans 510(k) Filing for Coronavirus Cannon
Shreis Scalene Therapeutics has announced that it will file for 510(k) clearance from the FDA for its Scalene Hypercharge Corona Cannon (SHYCOCAN), a device intended to disable viruses, including coronaviruses.
The device disables components of the SARS-CoV-2 spike protein by bombarding the virus with trillions of electrons per second. It is intended to disable airborne and surface virus particles, the Gaithersburg, Md.-based company said.
The SHYCOCAN has previously been granted CE mark certification as a Class I device, a category of devices with the lowest perceived risk.